-
Your prediction
Pros and Cons of Advanced Proteome Therapeutics in the next few years
Pros
Cons
Performance of Advanced Proteome Therapeutics vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Advanced Proteome Therapeutics | - | - | - | - | - | - | - |
Satellos Bioscience Inc. | - | 4.027% | -7.186% | -20.918% | 12.319% | -75.781% | - |
Burcon Nutrascience Corp. | 3.010% | -2.204% | 14.516% | 2.601% | 33.459% | -93.580% | -61.828% |
Sirona Biochem Corp. | 1.110% | -2.174% | 13.924% | -47.674% | -30.769% | -78.673% | -83.146% |
News
Nvidia Is Leading the Artificial Intelligence (AI) Charge, But These 2 Companies Are Rising Stars
AI chip leader Nvidia (NASDAQ: NVDA) will no doubt have very strong growth over the next year-plus. But while the chip designers like Nvidia and its would-be competitors garner a lot of headlines
1 Super Semiconductor Stock Down 42% You'll Wish You'd Bought on the Dip
Semiconductor stocks have been a focal point for investors over the past year, with the likes of Nvidia and Advanced Micro Devices winning most of the attention because of their fast-growing
Up More Than 70%, Is Nvidia Stock a Buy Right Now?
Many investors consider Nvidia (NASDAQ: NVDA) the ultimate artificial intelligence (AI) stock for two solid reasons: The company dominates the AI chip market and has turned this leadership into